HomeARQT • NASDAQ
Arcutis Biotherapeutics Inc
add
$13.51
1.81%
After Hours:(0.00%)0.00
$13.51
Closed: Jun 5, 7:31:28 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 65.85M | 32.84% |
Operating expense | 81.55M | 4.63% |
Net income | -25.06M | 29.17% |
Net profit margin | -38.06 | 46.68% |
Earnings per share | -0.20 | 37.50% |
EBITDA | -21.40M | 31.56% |
Effective tax rate | -1.13% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 198.09M | -50.95% |
Total assets | 344.11M | -28.09% |
Total liabilities | 201.45M | -20.56% |
Total equity | 142.66M | — |
Shares outstanding | 119.20M | — |
Price to book | 11.06 | — |
Return on assets | -17.70% | — |
Return on capital | -23.51% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -25.06M | 29.17% |
Cash from operations | -30.38M | 3.87% |
Cash from investing | 11.75M | 140.95% |
Cash from financing | 395.00K | -99.76% |
Net change in cash | -18.23M | -117.98% |
Free cash flow | -12.52M | 34.32% |
Previous close
$13.27
Day range
$13.04 - $13.73
Year range
$6.99 - $17.75
Market cap
1.61B USD
Avg Volume
1.97M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2016
Headquarters
Website
Employees
342
